Systemic side effects of ophthalmic drops.
D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D000068438:Brimonidine Tartrate; D002675:Child, Preschool; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009883:Ophthalmic Solutions; D011810:Quinoxalines / Q000008:administration & dosage / Q000009:adverse effects*
D000316:Adrenergic alpha-Agonists; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D000068438:Brimonidine Tartrate